Ceva Santé Animale (Ceva) is a multinational animal health company based in Libourne, France. Established in 1999, Ceva undertakes research, development, production and marketing of pharmaceutical products and vaccines, and also provides complementary services and equipment, for companion animals, poultry, ruminants and swine.
Ceva also supplies; hatchery vaccines, vaccination services and equipment; pheromone-based behavioural products for cats and dogs with additional knowledge in companion animal cardiology, locomotion and dermatology; products for the management of reproduction in ruminants such as antibiotic therapies and vaccines; and a growing range of products for swine, including antibiotic therapies, reproduction management and vaccines.
With revenues of US$1.16 billion (€1.1 billion) for 2017, Ceva is the 6th largest animal health company in the world and the biggest French multinational in the sector based on revenue.
Ceva is based in 45 countries and works in more than 110 countries worldwide. It has 12 research and development centres, 25 production sites and more than 5,500 employees.
In 2010, to mark its 10th anniversary, the company adopted a new mission statement, 'Together, we are building a new reference to create value beyond animal health', abbreviated in the slogan to 'Together, beyond animal health'.
The Chairman and CEO is Marc Prikazsky.
History
In 1999, two French pharmaceutical companies, Sanofi and Synthélabo, merged to form Sanofi-Synthélabo. Soon after the merger, the new company divested several businesses, including its animal health and nutrition business, Sanofi Santé Nutrition Animale.
This business was acquired through the first of four leveraged management buyouts (LMBO) and resulted in the establishment in 1999 of Ceva Santé Animal. Following the third LMBO, in 2007 Ceva management and employees acquired the majority shareholding in the company.
In 2014, there was a Reshaping of Ceva's capital structure to accompany the launch of the company's ambition to become the first independent player within the top 5 global animal health companies by 2020. While management still retained the position of majority shareholders long-term strategic partners were selected to support the group's future growth ambitions:Temasek, CDH Investments, Euromezzanine, Sagard and Mérieux Développement.
Since 1999, Ceva has been the sole shareholder of Ceva-Phylaxia. Founded in Hungary in 1912, the Phylaxia Vaccine Production Co produced the first vaccine against classical swine fever. Scientists including József Marek and Aladár Aujeszky were closely associated with the company.
Ceva has grown rapidly through both acquisitions and organic growth. In 2000 it ranked 18th globally with sales of US$140 million a year.
Major acquisitions by Ceva include:
2017: Purchase of ex-Merial product range
2017: Joint-venture agreement between EBVAC, China and Ceva to create a new business, Ceva Ebvac, focused on the swine vaccine sector 2016: Hertape Saude Animale Ltda. and Inova Biotecnologia Saude Animale Ltda, Brazil, 2016: Biovac, a manufacturer of autogeneous (bacterial) vaccines, allergy treatments and reagents based in Angers, France 2015: Polchem, India 2013: Sogeval 2011: Vetech Laboratories, Inc., a Canadian poultry vaccine manufacturer that produces live coccidiosis vaccines for poultry under the trade name Immucox® 2011: First joint venture established in China, Ceva Huadu 2010: Summit VetPharm, a New Jersey-based company 2005: Biomune, a US poultry vaccine producer based in Lenexa.
Awards and recognition
In 2016, Ceva won the best company in Europe category in Animal Pharm's annual industry awards.
In 2016, Ceva's hatchery vaccination services program for poultry, the C.H.I.C.K Program, received quality recognition from the international testing and certification company, Bureau Veritas Group, based in Paris. This was the first time a services program delivered by an animal health company had received internationally recognised quality approval.
Since 2005, Ceva has been awarded six International Cat Care (ICC) Easy to Give Awards. It has also received three ICC Cat Friendly Awards for products in the Feliway range. The Cat Friendly Awards recognise products which have made a real difference to cat wellbeing and welfare.
Key partnerships
Ceva established a partnership with the l'Association Chiens Guides d'Aveugles Aliénor (guide dogs for the blind association).